Skip to content

Evaluation of changes occuring in arm volume following surgery for breast cancer.

Lymphoedema in patients undergoing axillary surgery for carcinoma breast

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051580
Enrollment
90
Registered
2023-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I890- Lymphedema, not elsewhere classified Health Condition 2: C508- Malignant neoplasm of overlappingsites of breast

Interventions

None listed

Sponsors

Dr Padmaraj Hegde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with diagnosed breast cancer undergoing axillary lymph node dissection for carcinoma breast more than 6 months earlier.

Exclusion criteria

Exclusion criteria: 1) Recurrent breast cancer 2) More than one operative procedure performed 3) Metastatic disease to pleura/ lung/ bone 4) Male breast cancer

Design outcomes

Primary

MeasureTime frame
Assess objectively the volume changes in the arm, forearm and hand of the patients who have undergone axillary surgery for breast carcinoma.Timepoint: 6 months from date of surgery.

Secondary

MeasureTime frame
Assess functional deficit using LYMQOL questionnaire.Timepoint: 6 months from date of surgery.;Lymphoedema assessment using ISL/ILF stagingTimepoint: 6 months from date of surgery.;Lymphoedema assessment using Lymphoedema staging matrix.Timepoint: 6 months from date of surgery.;Lymphoedema assessment using WHO lymphoedema staging system.Timepoint: 6 months from date of surgery.

Countries

India

Contacts

Public ContactDr Sunil Krishna M

Kasturba Medical College, Manipal

stanley.mathew@manipal.edu9844409900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026